HEALTH AND PUBLIC POLICY COMMITTEE*
Each year approximately 115 000 cases of breast cancer are diagnosed in the United States; this malignancy is the commonest cause of cancer-related mortality in women (1). Because evidence exists that early detection is beneficial, such efforts may represent the best opportunity for the practicing physician to lessen cancer mortality in women. Screening for breast cancer in asymptomatic women depends upon tests with high sensitivity in order to detect cancer at early stages, whereas adequate specificity is required in order to avoid the financial and personal costs associated with unnecessary diagnostic efforts in women without malignancy. Evaluation of a palpable
HEALTH AND PUBLIC POLICY COMMITTEE*. The Use of Diagnostic Tests for Screening and Evaluating Breast Lesions. Ann Intern Med. ;103:143–146. doi: 10.7326/0003-4819-103-1-143
Download citation file:
Published: Ann Intern Med. 1985;103(1):143-146.
Healthcare Delivery and Policy, Prevention/Screening.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use